Home/Filings/4/0001493152-22-036653
4//SEC Filing

Gutfreund John Peter 4

Accession 0001493152-22-036653

CIK 0001642380other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 4:05 PM ET

Size

5.6 KB

Accession

0001493152-22-036653

Insider Transaction Report

Form 4
Period: 2022-12-23
Transactions
  • Purchase

    Common Stock, no par value

    2022-12-23$0.33/sh+75,000$24,72875,000 total(indirect: see footnote)
Footnotes (2)
  • [F1]The price of $0.3297 per share represents a weighted average of prices ranging from $0.31 to $0.33 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The shares of common stock are held by Newtown Road 130 Holdings LLC. The Reporting Person is the Managing Member of Newtown Road 130 Holdings LLC and in such capacity has the right to vote and dispose of the securities held by such entity.

Documents

1 file

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001940797

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 4:05 PM ET
Size
5.6 KB